Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Isabella Canazza, Andrea Ossato, Claudio Trapella, Anna Fantinati, Maria Antonietta De Luca, Giulia Margiani, Fabrizio Vincenzi, Claudia Rimondo, Fabiana Di Rosa, Adolfo Gregori, Katia Varani, Pier Andrea Borea, Giovanni Serpelloni, Matteo Marti
Psychopharmacology October 2016 DOI: 10.1007/s00213-016-4402-y (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical in vitro and in vivo pharmacological study Peer reviewed |
|---|---|
| Population | Male CD-1 mice |
| Interventions | AKB48 5F-AKB48 Δ9-THC JWH-018 AM 251 |
| Keywords | 5f-akb48 Behavior Jwh-018 Microdialysis Sensorimotor responses Synthetic cannabinoids δ9-THC |
| Key points | AKB48 and 5F-AKB48 bind CB1 and CB2 receptors with nanomolar affinity and produce a full Cannabis-like pharmacological profile in mice, including hypothermia, antinociception, catalepsy, reduced motor activity, impaired sensorimotor responses, seizures and aggression, plus increased nucleus accumbens dopamine release. All effects were prevented by the CB1 antagonist AM 251. The authors suggest fluorination may increase the power or effectiveness of synthetic cannabinoids and outline potential detrimental effects on human health. |
Abstract
AKB48 and its fluorinate derivate 5F-AKB48 are two novel synthetic cannabinoids belonging to a structural class with an indazole core structure. They are marketed as incense, herbal preparations or chemical supply for their psychoactive Cannabis-like effects. The present study was aimed at investigating the in vitro and in vivo pharmacological activity of AKB48 and 5F-AKB48 in male CD-1 mice and comparing their in vivo effects with those caused by the administration of Δ9-THC and JWH-018. In vitro competition binding experiments performed on mouse and human CB1 and CB2 receptors revealed a nanomolar affinity and potency of the AKB48 and 5F-AKB48. In vivo studies showed that AKB48 and 5F-AKB48, induced hypothermia, increased pain threshold to both noxious mechanical and thermal stimuli, caused catalepsy, reduced motor activity, impaired sensorimotor responses (visual, acoustic and tactile), caused seizures, myoclonia, hyperreflexia and promoted aggressiveness in mice. Moreover, microdialysis study in freely moving mice showed that systemic administration of AKB48 and 5F-AKB48 stimulated dopamine release in the nucleus accumbens. Behavioural, neurological and neurochemical effects were fully prevented by the selective CB1 receptor antagonist/inverse agonist AM 251. For the first time, the present study demonstrates the overall pharmacological effects induced by the administration of AKB48 and 5F-AKB48 in mice and suggests that the fluorination can increase the power and/or effectiveness of SCBs. Furthermore, this study outlines the potential detrimental effects of SCBs on human health.
Citations in the library
Cited by 15
- Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data? Pharmacology & Therapeutics February 1, 2018
- Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences September 3, 2020
- Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset CNS & Neurological Disorders - Drug Targets April 17, 2017
- Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs Brain Sciences March 13, 2018
- Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence. Psychopharmacology March 1, 2024
and 10 more in the library
Cites 9
- Novel psychoactive substances of interest for psychiatry World Psychiatry February 1, 2016
- Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Frontiers in Neuroscience April 19, 2016
- Effect of JWH-250, JWH-073 and their interaction on "tetrad", sensorimotor, neurological and neurochemical responses in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry June 3, 2016
- Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice. Neuropharmacology August 2015
- Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market. Behavioural Pharmacology August 2015
and 4 more in the library